1152P Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI). - Costa Svedman, F.; Liapi, M.; Chatzidionysiou, A.; Månsson-Broberg, A.; Egyhazi Brage, S. (Annals of Oncology, 2023)